Satellos Bioscience Inc.
MSCLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $84,649 | $83,901 | $93,757 | $95,901 |
| - Cash | $19,304 | $38,217 | $32,712 | $57,659 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $65,345 | $45,684 | $61,045 | $38,242 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2 | -$1 | -$6,535 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,963 | -$6,366 | -$6,478 | -$6,094 |
| % Margin | – | – | – | – |
| Net Income | -$5,756 | -$5,608 | -$6,141 | -$6,106 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.034 | -0.045 | -0.053 | -0.054 |
| % Growth | 22.9% | 16.3% | 1.3% | – |
| Operating Cash Flow | -$4,126 | -$4,843 | -$7,366 | -$7,808 |
| Capital Expenditures | -$3 | -$3 | $0 | $0 |
| Free Cash Flow | -$4,129 | -$4,846 | -$7,366 | -$7,808 |